MicroRNA-297b-5p/3p target Mllt3/Af9 to suppress lymphoma cell proliferation, migration and invasion in vitro and tumor growth in nude mice

Leukemia and Lymphoma

Volumn 53, Issue 10, 2012, Pages 2033-2040

  Zhang, Tiantian ^a   Luo, Yu ^b   Wang, Tao ^a   Yang, James Y ^a  

^a XIAMEN UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Lymphoma; MiR 297b 5p 3p; Mllt3 Af9; P27Kip1; PCNA

Indexed keywords

AF9 PROTEIN; CELL NUCLEUS ANTIGEN; MICRORNA; MIR 297B 5P 3P; MLLT3 PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; IN VITRO STUDY; LYMPHOMA; LYMPHOMA CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR GROWTH;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOMA; MICE; MICE, NUDE; MICRORNAS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 84865779225     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.678005     Document Type: Article

References (26)

1. Schulze JM, Wang AY, Kobor MS. YEATSdomain proteins: a diverse family with many links to chromatin modification and transcription. Biochem Cell Biol 2009;87:65-75.
2. Zeisig DT, Bittner CB, Zeisig BB, et al. The eleven-nineteenleukemia protein ENLconnects nuclear MLLfusion partners with chromatin. Oncogene 2005;24:5525-5532.
3. Iida S, Seto M, Yamamoto K, et al. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene 1993;8:3085-3092.
4. May G, Soneji S, et al. MLLT3 regulates early human erythroid and megakaryocytic cell fate. Cell Stem Cell 2008;2:264-273.
5. Park G, Gong Z, Chen J, et al. Characterization of the DOT1Lnetwork: implications of diverse roles for DOT1L. Protein J2010;29: 213-223.
6. Rubnitz JE, Morrissey J, Savage PA, et al. ENL, the gene fused with HRXin t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 1994;84:1747-1752.
7. Corral J, Lavenir I, Impey H, et al. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 1996;85:853-861.
8. Hemenway CS, de Erkenez AC, Gould GC. The polycomb protein MPc3 interacts with AF9, an MLLfusion partner in t(9;11)(p22;q23) acute leukemias. Oncogene 2001;20:3798-3805.
9. Srinivasan RS, de Erkenez AC, Hemenway CS. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor. Oncogene 2003;22:3395-3406.
10. Vogel T, Gruss P. Expression of leukaemia associated transcription factor Af9/Mllt3 in the cerebral cortex of the mouse. Gene Expr Patterns 2009;9:83-93.
11. Buttner N, Johnsen SA, Kugler S, et al. Af9/Mllt3 interferes with Tbr1 expression through epigenetic modification of histone H3K79 during development of the cerebral cortex. Proc Natl Acad Sci USA2010;107:7042-7047.
12. Collins EC, Appert A, Ariza-McNaughton L, et al. Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia. Mol Cell Biol 2002;22:7313-7324.
13. Pramparo T, Grosso S, Messa J, et al. Loss-of-function mutation of the AF9/MLLT3 gene in a girl with neuromotor development delay, cerebellar ataxia, andepilepsy. Hum Genet 2005;118:76-81.
14. Huang W, Liu H, Wang T, et al. Tonicity-responsive microRNAs contribute to the maximal induction of osmoregulatory transcription factor OREBPin response to high-NaCl hypertonicity. Nucleic Acids Res 2011;39:475-485.
15. Zheng GX, Ravi A, Gould GM, et al. Genome-wide impact of a recently expanded microRNAcluster in mouse. Proc Natl Acad Sci USA2011;108:15804-15809.
16. Neilson JR, Zheng GX, Burge CB, et al. Dynamic regulation of miRNAexpression in ordered stages of cellular development. Genes Dev 2007;21:578-589.
17. Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008;18:131-140.
18. Zheng GX. Exploring the regulatory roles of microRNAs in mammalian development [Dissertation]. Boston: MIT; 2010.
19. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA2009;106:4402-4407.
20. Sun Y, Wu J, Wu SH, et al. Expression profile of microRNAs in c-Myc induced mouse mammary tumors. Breast Cancer Res Treat 2009;118:185-196.
21. Maes OC, An J, Sarojini H, et al. Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev 2008;129: 534-541.
22. Fabbri M, Croce CM. Role of microRNAs in lymphoid biology and disease. Curr Opin Hematol 2011;18:266-272.
23. Fabbri M, Croce CM, Calin GA. MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk Lymphoma 2009;50:160-170.
24. Volinia S, Galasso M, Costinean S, et al. Reprogramming of miRNAnetworks in cancer and leukemia. Genome Res 2010;20: 589-599.
25. Li SC, Tang P, Lin WC. Intronic microRNA: discovery and biological implications. DNACell Biol 2007;26:195-207.
26. Jafarifar F, Yao P, Eswarappa SM, et al. Repression of VEGFAby CA-rich element-binding microRNAs is modulated by hnRNPL. EMBOJ2011;30:1324-1334.